 |
 |
|
Northern Lincolnshire
Formulary |
| Formulary Chapter 9: Nutrition and blood - Full Section
|
Notes:
Guideline for the appropriate use of Oral Nutritional Supplements (ONS) for adults in primary care
Oral Nutritional Supplement Prescribing Statement
|
| Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
|
|
09.01 |
Anaemias and some other blood disorders
(0,1)
|
|
09.01.01 |
Iron-deficiency anaemias
(0,0)
|
|
09.01.01.01 |
Oral iron
(4,2)
|
|
|
Iron and folic acid
(1,0)
|
|
09.01.01.02 |
Parenteral iron
(3,0)
|
|
09.01.02 |
Drugs used in megaloblastic anaemias
(3,0)
|
|
09.01.03 |
Drugs used in hypoplastic, haemolytic, and renal anaemias
(1,0)
|
|
|
Erythropoietin
(3,0)
|
|
|
Iron overload
(1,0)
|
|
09.01.04 |
Drugs used in autoimmune thrombocytopenic purpura
(5,0)
|
|
09.01.05 |
G6PD deficiency
(0,0)
|
|
09.01.06 |
Drugs used in neutropenia
(2,0)
|
|
09.01.07 |
Drugs used to mobilise stem cells
(1,0)
|
|
09.02 |
Fluids and electrolytes
(0,0)
|
|
09.02.01 |
Oral preparations for fluid and electrolyte imbalance
(0,0)
|
|
09.02.01.01 |
Oral potassium
(2,0)
|
|
|
Potassium removal
(2,0)
|
|
09.02.01.02 |
Oral sodium and water
(1,0)
|
|
|
Oral rehydration therapy (ORT)
(1,0)
|
|
09.02.01.03 |
Oral bicarbonate
(1,0)
|
|
09.02.02 |
Parenteral preparations for fluid and electrolyte imbalance
(0,0)
|
|
09.02.02.01 |
Electrolytes and water
(0,0)
|
|
|
Intravenous sodium
(1,0)
|
|
|
Intravenous glucose
(6,0)
|
|
|
Intravenous potassium
(6,0)
|
|
|
Bicarbonate and lactate
(2,0)
|
|
|
Water
(1,0)
|
|
09.02.02.02 |
Plasma and plasma substitutes
(0,0)
|
|
|
Plasma substitutes
(3,0)
|
|
09.03 |
Intravenous nutrition
(6,0)
|
|
|
Supplementary preparations
(0,0)
|
|
09.04 |
Oral nutrition
(0,0)
|
|
09.04.01 |
Foods for special diets
(1,0)
|
|
09.04.02 |
Enteral nutrition
(0,0)
|
|
09.05 |
Minerals
(0,0)
|
|
09.05.01 |
Calcium and magnesium
(0,0)
|
|
09.05.01.01 |
Calcium supplements
(3,0)
|
|
09.05.01.02 |
Hypercalcaemia and hypercalciuria
(1,0)
|
|
09.05.01.03 |
Magnesium
(0,0)
|
|
09.05.02 |
Phosphorus
(0,0)
|
|
09.05.02.01 |
Phosphate supplements
(2,0)
|
|
09.05.02.02 |
Phosphate-binding agents
(0,0)
|
|
09.05.03 |
Fluoride
(0,0)
|
|
09.05.04 |
Zinc
(1,0)
|
|
09.05.05 |
Selenium
(0,0)
|
|
09.06 |
Vitamins
(0,0)
|
|
09.06.01 |
Vitamin A
(0,0)
|
|
09.06.02 |
Vitamin B group
(2,0)
|
|
|
Oral vitamin B complex preparations
(1,0)
|
|
|
Other compounds
(0,0)
|
|
09.06.03 |
Vitamin C
(1,0)
|
|
09.06.04 |
Vitamin D
(5,0)
|
|
09.06.05 |
Vitamin E
(0,0)
|
|
09.06.06 |
Vitamin K
(4,0)
|
|
09.06.07 |
Multivitamin preparations
(0,1)
|
|
|
Vitamin and mineral supplements and adjuncts to synthetic diets
(1,0)
|
|
09.07 |
Bitters and tonics
(0,0)
|
|
09.08 |
Metabolic disorders
(0,0)
|
|
09.08.01 |
Drugs used in metabolic disorders
(0,0)
|
|
|
Wilsons disease
(0,0)
|
|
|
Carnitine deficiency
(0,0)
|
|
|
Fabry's disease
(0,0)
|
|
|
Gaucher's disease
(0,0)
|
|
|
Mucopolysaccharidosis I
(0,0)
|
|
|
Pompe disease
(0,0)
|
|
|
Nephropathic cystinosis
(0,0)
|
|
|
Urea cycle disorders
(0,0)
|
|
09.08.02 |
Acute porphyrias
(0,0)
|
|
|
Drugs unsafe for use in acute porphyrias
(0,0)
|
|
|
|
